During the Meeting of Experts of states parties to the Biological and Toxin Weapons Convention (BTWC) last August, the Netherlands organised or co-hosted three side events relating to safeguarding the life sciences. A significant incident, in which the Dutch virologist Ron Fouchier and his team were required to obtain an export licence to publish their research on how they had mutated H5N1 into an aerosol-transmissible avian influenza virus variant, undeniably informed the need to clarify national policies and approaches to biorisk management. A month earlier the Appellate Court had annulled the ruling by a lower court in support of the government position on procedural grounds. Does this annulment validate the Dutch government’s position or does it imply that the whole debate about the publication of so-called dual-use research in the life sciences is back to square one? Moreover, in the meantime the debate had evolved from a terrorist proliferation risk to one of health security in which the ethics and utility of this type of gain-of-function research stand central. In other words, do biosafety worries warrant biosecurity policy measures, such as the imposition of non-proliferation export controls?
By Brett Edwards, James Revill, and Valentina Cartei
December 2, 2015 11.13am GMT
Republished from The Conversation
The use of acid as part of violent crime is apparently on the rise in the UK, and various efforts are being made to reverse what’s become a very disturbing trend
The Daily Express has started a campaign to “end the evil of acid attacks”, hot on the heels of a similar initiative by The Sun. Both campaigns focus on restricting access to the types of acid most commonly used in such attacks. The Express has launched a petition demanding that “the sale of any acid which could be used as a weapon be properly licensed”.